Pasar al contenido principal

ESTUDIO DE LAS ADAPTACIONES DEL MICROAMBIENTE QUE CONTROLAN LA REGENERACION/REPARACION CARDIACA

PID2021-123925OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO INSTITUT D INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model

  • Blasco-Agell, Lucas
  • Pons-Espinal, Meritxell
  • Testa, Veronica
  • Roch, Gerard|||0000-0002-9045-0579
  • Montero-Muñoz, Jara
  • Fernandez Carasa, Irene|||0000-0002-8195-3510
  • Baruffi, Valentina
  • González Sepúlveda, Marta|||0000-0002-5627-847X
  • Richaud-Patin, Yvonne
  • Jimenez, Senda
  • Cuadros, Thais|||0000-0001-6994-2424
  • Cladera-Sastre, Joana Margalida
  • Compte, Joan|||0000-0001-5447-5122
  • Manglano-Artuñedo, Zoe
  • Ventura, Salvador|||0000-0002-9652-6351
  • Juan, Manel|||0000-0002-3064-1648
  • Tolosa, Eduardo
  • Raya, Ángel|||0000-0003-2189-9775
  • Vila Bover, Miquel|||0000-0002-1352-989X
  • Consiglio, Antonella
Parkinson's disease (PD) is a progressive, incurable neurodegenerative disorder characterized by the loss of neuromelanin (NM)-containing dopamine neurons (DAn) in the substantia nigra of the midbrain. Non-neuronal cells are increasingly recognized as contributors to PD. We generated human microglia-like cells (hMG) from induced pluripotent stem cells (iPSC) derived from patients with LRRK2 PD-causing mutations, gene-corrected isogenic controls, and healthy donors. While neither genotype induced neurodegeneration in healthy DAn, LRRK2 hMG become hyperreactive to LPS stimulation, exhibiting increased cytokine expression, reactive oxygen species, and phagocytosis. When exposed to NM-containing particles, but not α-synuclein fibrils, LRRK2 hMG trigger DAn degeneration, in a process that is prevented by pre-treatment with the immunomodulatory drug ivermectin. Finally, post-mortem analysis of midbrain tissue of LRRK2-PD patients show increased microglia activation around NM-containing neurons, confirming our in vitro findings. Overall, our work highlights NM-activated microglia's role in PD progression, and provides a model for testing therapeutic targets. (Figure presented.).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs

  • Reinal-Ferre, Ignacio|||0000-0001-8678-945X
  • Fambuena-Santos, Carlos
  • Andreu M. Climent|||0000-0002-7260-8811
  • Ontoria-Oviedo, Imelda
  • Selva, Marta
  • Casini, Marilù
  • Peiró-Molina, Esteban
  • Balaguer, Julia
  • Cañete, Adela
  • Mora, Jaume
  • Raya, Ángel
  • Sepúlveda, Pilar
[EN] Anthracyclines are widely used in the treatment of many solid cancers, but their efficacy is limited by cardiotoxicity. As the number of pediatric cancer survivors continues to rise, there has been a concomitant increase in people living with anthracycline-induced cardiotoxicity. Accordingly, there is an ongoing need for new models to better understand the pathophysiological mechanisms of anthracycline-induced cardiac damage. Here we generated induced pluripotent stem cells (iPSCs) from two pediatric oncology patients with acute cardiotoxicity induced by anthracyclines and differentiated them to ventricular cardiomyocytes (hiPSC-CMs). Comparative analysis of these cells (CTX hiPSC-CMs) and control hiPSC-CMs revealed that the former were significantly more sensitive to cell injury and death from the anthracycline doxorubicin (DOX), as measured by viability analysis, cleaved caspase 3 expression, oxidative stress, genomic and mitochondrial damage and sarcomeric disorganization. The expression of several mRNAs involved in structural integrity and inflammatory response were also differentially affected by DOX. Functionally, optical mapping analysis revealed higher arrythmia complexity after DOX treatment in CTX iPSC-CMs. Finally, using a panel of previously identified microRNAs associated with cardioprotection, we identified lower levels of miR-22-3p, miR-30b-5p, miR-90b-3p and miR-4732-3p in CTX iPSC-CMs under basal conditions. Our study provides valuable phenotype information for cellular models of cardiotoxicity and highlights the significance of using patient-derived cardiomyocytes for studying the associated pathogenic mechanisms., This research was funded in part by grants from the Instituto de Salud Carlos III PI19/0245, PI22/00230, and RETICS TERCEL (RD16/0011/0004 and RD16/0011/0024), co-funded by FEDER una manera de hacer Europa , from the Spanish Ministry of Science and Innovation-MCIN (PID2021-123925OB-I00), AGAUR (2021-SGR-974) and CERCA Programme/Generalitat de Catalunya. It was also supported by predoctoral fellowships to I.R. and M.S., grants ACIF2019/250 and ACIF/2021/389, from the Conselleria de Sanitat Universal i Salut Pública and co-financed by the European Union through the Operational Program of the European Regional Development Fund (FEDER) of the Valencian Community 2014 2020.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation

  • Tristán-Noguero, Alba
  • Fernández-Carasa, Irene
  • Calatayud, Carles
  • Bermejo-Casadesús, Cristina
  • Pons-Espinal, Meritxell
  • Colini Baldeschi, Arianna
  • Campa, Leticia
  • Artigas, Francesc
  • Bortolozzi, Analía
  • Domingo-Jiménez, Rosario
  • Ibáñez, Salvador
  • Pineda, Mercè
  • Artuch, Rafael
  • Raya, Ángel
  • García-Cazorla, Àngels
  • Consiglio, Antonella
Tyrosine hydroxylase deficiency (THD) is a rare genetic disorder leading to dopaminergic depletion and early-onset Parkinsonism. Affected children present with either a severe form that does not respond to L-Dopa treatment (THD-B) or a milder L-Dopa responsive form (THD-A). We generated induced pluripotent stem cells (iPSCs) from THD patients that were differentiated into dopaminergic neurons (DAn) and compared with control-DAn from healthy individuals and gene-corrected isogenic controls. Consistent with patients, THD iPSC-DAn displayed lower levels of DA metabolites and reduced TH expression, when compared to controls. Moreover, THD iPSC-DAn showed abnormal morphology, including reduced total neurite length and neurite arborization defects, which were not evident in DAn differentiated from control-iPSC. Treatment of THD-iPSC-DAn with L-Dopa rescued the neuronal defects and disease phenotype only in THDA-DAn. Interestingly, L-Dopa treatment at the stage of neuronal precursors could prevent the alterations in THDB-iPSC-DAn, thus suggesting the existence of a critical developmental window in THD. Our iPSC-based model recapitulates THD disease phenotypes and response to treatment, representing a promising tool for investigating pathogenic mechanisms, drug screening, and personalized management., The authors are indebted to the THD patients who have participated in this study. The authors thank Bernd Kuebler and Begoña Aran from the P-CMR[C] Stem Cell Bank, for generating the THD iPSCs. We would like to thank Marcia Triunfol and João Mello-Vieira at Publicase for their help with this manuscript. Research from the authors' laboratories is supported by the European Research Council-ERC (2012-StG-311736-PD-HUMMODEL) and ERC 2020-PoC (957581 NeurAntigen), the Spanish Ministry of Economy and Competitiveness-MINECO (PID2019-108792GB-I00, PID2019-105136RB-100, PID2021-123925OB-I00, PDC2021-121051-I00 and RTI2018-095377-B-100), supported by MCIN/AEI/10.13039/501100011033 and “NextGenerationEU/PRTR”, Instituto de Salud Carlos III-ISCIII/ and “Fondo Europeo de desarrollo regional” (FEDER) (Red de Terapia Celular - TerCel RD16/0011/0024, FIS PI15/01082, P118/00111), Agencia Estatal de Investigación-AEI (Unidad de Excelencia María de Maeztu CEX2018-000792-M), AGAUR (2017-SGR-899 and 2017-SGR-1061), Fundació la Marató de TV3 (202012-31 and 202012-32) and CERCA Programme/Generalitat de Catalunya. CC was partially supported by predoctoral fellowship (FPU12/03332) from the Spanish Ministry of Education (MEC). AT-N was partially supported by a PFIS pre-doctoral fellowship (FI14/00641) from the Instituto de Salud Carlos III-ISCIII and 2018BR-IRSJD-CdTorres from Sant Joan de Déu Hospital. AC is a recipient of an ICREA “Academia” Award (Generalitat de Catalunya)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Tri-Culture Heart-on-a-Chip Platform With iPSC-Derived Cardiac Cells for Predictive Cardiotoxicity Testing

  • Tadevosyan, Karine
  • Yeste, Jose
  • Alvarez, Mar
  • Marrero, Denise
  • Casado-Medina, Laura
  • Richaud-Patin, Yvonne
  • García-Iglesias, Olalla
  • Litowczenko, Jagoda
  • Garcia, Alba Morillas
  • Guimerà, Anton
  • Illa, Xavi
  • Villa, Rosa
  • Raya, Angel
Drug development is hindered by high attrition rates, with clinical trial failures accounting for 90% of unsuccessful candidates and 60% of R&D costs, often due to unanticipated cardiotoxicity. Existing models lack physiological relevance, particularly the vascular component critical for drug distribution and cardioprotection. To address this, we developed a heart-on-a-chip (HoC) platform integrating human induced pluripotent stem cell (iPSC)-derived cardiomyocytes, cardiac fibroblasts, and endothelial cells from a single cell line, ensuring genetic uniformity and native-like cell-cell interactions. The tri-culture system maintained >90% cell viability under perfusion for 7 days and exhibited functional maturity, as demonstrated by expected chronotropic responses to the β-agonist isoproterenol. Crucially, the inclusion of endothelial cells mitigated doxorubicin-induced cardiotoxicity, a protective effect absent in conventional models, highlighting the endothelial layer's role in replicating in vivo drug responses. By combining physiological mimicry with scalability, this HoC platform offers a transformative tool for improving preclinical cardiotoxicity assessment and reducing reliance on animal models., The authors are indebted to the Histology and Bioimaging Platforms of IDIBELL Scientific and Technical Services and to the Micro NanoTechnology Unit U8 (IMB-CNM, CSIC), which is ascribed to the NANBIOSIS ICTS of CIBER-BBN, for their support. This research was funded by the Spanish Ministry of Science, Innovation, and Universities-MICIU (grants PID2021-123925OB-I00, PDC2023 145822 I00, and PID2024-15802908OB-I00), AGAUR (2021-SGR-974), Fundació La Marató de TV3 (202331-30), Fundació Obra Social la Caixa LCF/PR/HR23/52430011), and CERCA Programme /Generalitat de Catalunya. IMB CNM is supported by the María de Maeztu program for Units of Excellence, grant CEX2023 001397 M, funded by MICIU/AEI/10.13039/501100011033. LC-M was partially supported by apre-doctoral fellowship from MICIU (FPU19/01718)., Peer reviewed